In their study, concerning the findings in CTPA, i.e., pulmonary embolism and parenchymal abnormalities, Jalde et al. also noted that a larger MPAD positively correlated with extended parenchymal abnormalities, high C-reactive protein levels, and a poor disease outcome in 130 patients in Sweden [29]. This evidence concerns the gene CRP and pulmonary embolism.